Literature DB >> 10456365

High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus.

S Sookoian, V Neglia, G Castaño, B Frider, M C Kien, E Chohuela.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10456365     DOI: 10.1001/archderm.135.8.1000

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  4 in total

1.  Generalised Dermatitis Induced by Pegylated Interferon-alpha-2b in a Patient Infected with Genotype-1 Hepatitis C Virus : Presentation of a Case.

Authors:  L Gallelli; M Ferraro; G F Mauro; G De Sarro
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

2.  Tongue hyperpigmentation resulting from peginterferon alfa-2b and ribavirin treatment in a patient with chronic hepatitis C.

Authors:  Souvik Ghosh; Ajay Duseja; Radha Krishan Dhiman; Yogesh Kumar Chawla
Journal:  Dig Dis Sci       Date:  2011-09-24       Impact factor: 3.199

Review 3.  A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin.

Authors:  Nisha Mistry; Jonathan Shapero; Richard I Crawford
Journal:  Can J Gastroenterol       Date:  2009-10       Impact factor: 3.522

4.  Lack of association between pandemic chilblains and SARS-CoV-2 infection.

Authors:  Jeff R Gehlhausen; Alicia J Little; Christine J Ko; Marc Emmenegger; Carolina Lucas; Patrick Wong; Jon Klein; Peiwen Lu; Tianyang Mao; Jillian Jaycox; Eric Wang; Nelson Ugwu; Cate Muenker; Dilgash Mekael; Rhonda Q Klein; Robert Patrignelli; Richard Antaya; Jennifer McNiff; William Damsky; Kathy Kamath; John Shon; Aaron M Ring; Inci Yildirim; Saad Omer; Albert I Ko; Adriano Aguzzi; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-01       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.